1. Home
  2. AMRC vs NBTX Comparison

AMRC vs NBTX Comparison

Compare AMRC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameresco Inc.

AMRC

Ameresco Inc.

HOLD

Current Price

$26.82

Market Cap

1.6B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$35.99

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRC
NBTX
Founded
2000
2003
Country
United States
France
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
AMRC
NBTX
Price
$26.82
$35.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$37.88
$36.00
AVG Volume (30 Days)
569.5K
55.9K
Earning Date
05-04-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,769,928,000.00
N/A
Revenue This Year
$10.71
$58.17
Revenue Next Year
$9.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
28.76
N/A
52 Week Low
$14.88
$4.57
52 Week High
$44.93
$57.14

Technical Indicators

Market Signals
Indicator
AMRC
NBTX
Relative Strength Index (RSI) 40.82 44.58
Support Level $24.44 $30.15
Resistance Level $27.25 $38.29
Average True Range (ATR) 1.67 2.68
MACD -0.20 -0.06
Stochastic Oscillator 32.62 51.59

Price Performance

Historical Comparison
AMRC
NBTX

About AMRC Ameresco Inc.

Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: